Castle Biosciences Inc Forecast, price target & analysts
Castle Biosciences Inc Target price 2026 - Analyst rating & recommendation
Castle Biosciences Inc Classifications & Recommendation:
Castle Biosciences Inc Price Target
| Target Price | $38.25 |
| Price | $38.54 |
| Deviation |
0.75%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Castle Biosciences Inc 2027 .
The average Castle Biosciences Inc target price is $38.25.
This is
0.75%
register free of charge
$47.25
22.60%
register free of charge
$30.30
21.38%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Castle Biosciences Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Castle Biosciences Inc stock has an average upside potential 2027 of
0.75%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 332.07 | 337.68 |
| 51.09% | 1.69% | |
| EBITDA Margin | 6.54% | 9.96% |
| 125.04% | 52.28% | |
| Net Margin | 5.50% | -9.89% |
| 121.02% | 279.95% |
10 Analysts have issued a sales forecast Castle Biosciences Inc 2025 . The average Castle Biosciences Inc sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Castle Biosciences Inc EBITDA forecast 2025. The average Castle Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Castle Biosciences Inc Analysts have issued a net profit forecast 2025. The average Castle Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.62 | -1.15 |
| 128.97% | 285.48% | |
| P/E | negative | |
| EV/Sales | 2.51 |
10 Analysts have issued a Castle Biosciences Inc forecast for earnings per share. The average Castle Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Castle Biosciences Inc...
Current Castle Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Dec 22 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | May 21 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Dec 22 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 09 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
